Brzosko S, Hryszko T, Lebkowska U, Malyszko J, Malyszko J S, Mysliwiec M
Department of Nephrology and Transplantology, Bialystok Medical Academy, Zurawia 14, Bialystok 15-336, Poland.
Transplant Proc. 2003 Dec;35(8):2931-4. doi: 10.1016/j.transproceed.2003.10.089.
The majority of deaths among patients after renal transplantation is attributed to cardiovascular disease (CVD). Intima media thickness (IMT) of the common carotid artery is related to coronary and cerebrovascular arterial disease. One of the major causes of death due to CVD is acute coronary syndrome, which is precipitated by coronary plaque rupture and subsequent thrombosis. The aim of the study was to evaluate associations between some fibrinolytic factors: antigens of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor (PAI-1), and thrombin-activatable fibrinolysis inhibitor (TAFI), and IMT in a population of renal transplant recipients. The study was performed on 33 Caucasian, clinically stable kidney transplant recipients (11 women, mean age 43 years, range 26 to 62 years). All the patients were on triple immunosuppressive regimen (cyclosporine, prednisone, and azathioprine) and had stable graft function (serum creatinine 1.7 +/- 0.7 mg/dL). The mean time since transplantation was 49.9 months (range 4.1 to 131.8 months). In univariate analysis IMT correlated significantly with age (r =.5; P =.001), pulse pressure (PP) (r =.4; P =.05), time on dialysis prior to transplantation (r =.6; P =.001), fibrinogen (r =.4; P =.02), and t-PA (r =.6; P =.001). Multiple regression analysis showed that t-PA antigen concentration (P =.001), fibrinogen (P <.05), and time on dialysis prior to transplantation (P <.05) were positive independent predictors of IMT. These data support the concept of the coincidence of disturbances in fibrinolysis and arterial remodelling in patients after kidney transplantation. On the other hand the study shows that the duration of dialysis therapy before transplantation is detrimental to the arterial vasculature.
肾移植患者的大多数死亡归因于心血管疾病(CVD)。颈总动脉内膜中层厚度(IMT)与冠状动脉和脑血管疾病有关。CVD导致死亡的主要原因之一是急性冠状动脉综合征,它由冠状动脉斑块破裂及随后的血栓形成所引发。本研究的目的是评估肾移植受者群体中一些纤溶因子:组织型纤溶酶原激活物(t-PA)抗原、纤溶酶原激活物抑制剂(PAI-1)和凝血酶激活的纤溶抑制物(TAFI)与IMT之间的关联。该研究对33名临床稳定的白种人肾移植受者进行(11名女性,平均年龄43岁,范围26至62岁)。所有患者均采用三联免疫抑制方案(环孢素、泼尼松和硫唑嘌呤),且移植肾功能稳定(血清肌酐1.7±0.7mg/dL)。移植后的平均时间为49.9个月(范围4.1至131.8个月)。单因素分析中,IMT与年龄(r = 0.5;P = 0.001)、脉压(PP)(r = 0.4;P = 0.05)、移植前透析时间(r = 0.6;P = 0.001)、纤维蛋白原(r = 0.4;P = 0.02)和t-PA(r = 0.6;P = 0.001)显著相关。多元回归分析显示,t-PA抗原浓度(P = 0.001)、纤维蛋白原(P < 0.05)和移植前透析时间(P < 0.05)是IMT的独立阳性预测因子。这些数据支持肾移植患者纤溶紊乱与动脉重塑同时存在的概念。另一方面,该研究表明移植前透析治疗的持续时间对动脉血管系统有害。